+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulation of Eryptosis by Narasin



Stimulation of Eryptosis by Narasin



Cellular Physiology and Biochemistry 37(5): 1807-1816



Narasin, an ionophore used for the treatment of coccidiosis, has been shown to foster apoptosis of tumor cells. In analogy to apoptosis of nucleated cells, erythrocytes may enter eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Eryptosis may be triggered by Ca2+ entry with subsequent increase of cytosolic Ca2+ activity ([Ca2+]i), and by ceramide. The present study explored, whether and how narasin induces eryptosis. Flow cytometry was employed to estimate phosphatidylserine exposure at the cell surface from annexin-V-binding, cell volume from forward scatter, [Ca2+]i from Fluo3-fluorescence, and ceramide abundance utilizing specific antibodies. A 48 hours exposure of human erythrocytes to narasin (10 and 25 ng/ml) significantly increased the percentage of annexin-V-binding cells. Forward scatter was decreased by 1 ng/ml narasin but not by higher narasin concentrations (10 and 25 ng/ml). Narasin significantly increased Fluo3-fluorescence (10 and 25 ng/ml) and slightly, but significantly increased ceramide abundance (25 ng/ml). The effect of narasin on annexin-V-binding was significantly blunted, but not abolished by removal of extracellular Ca2+. Narasin triggers phospholipid scrambling of the erythrocyte cell membrane, an effect paralleled and partially dependent on Ca2+ entry. Narasin further leads to cell shrinkage and slight increase of ceramide abundance.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905847

Download citation: RISBibTeXText

PMID: 26584281

DOI: 10.1159/000438543


Related references

Stimulation of eryptosis by cryptotanshinone. Cellular Physiology and Biochemistry 34(2): 432-442, 2015

Stimulation of Eryptosis by Afatinib. Cellular Physiology and Biochemistry 47(3): 1259-1273, 2018

Stimulation of Eryptosis by Caspofungin. Cellular Physiology and Biochemistry 39(3): 939-949, 2016

Stimulation of eryptosis by anti-A IgG antibodies. Cellular Physiology and Biochemistry 20(5): 591-600, 2007

Stimulation of eryptosis by aluminium ions. Toxicology and Applied Pharmacology 217(2): 168-175, 2006

Stimulation of eryptosis by cadmium ions. Cellular Physiology and Biochemistry 22(1-4): 245-252, 2008

Sulindac sulfide--induced stimulation of eryptosis. Cellular Physiology and Biochemistry 30(4): 1072-1082, 2013

Field isolates of E. tenella: sensitivity to diclazuril, maduramicin, narasin, salinomycin and a mixture of nicarbazin/narasin. Coccidia and intestinal coccidiomorphs Proceedings of the 5th International Coccidiosis Conference Tours France, 17-20 October 1989: 323-326, 1989

Stimulation of Eryptosis by Combretastatin A4 Phosphate Disodium (CA4P). Cellular Physiology and Biochemistry 38(3): 969-981, 2016

Stimulation of Eryptosis, the Suicidal Erythrocyte Death by Piceatannol. Cellular Physiology and Biochemistry 38(6): 2300-2310, 2016

Development of resistance against narasin and narasin plus nicarbazin. Poultry Science 68(SUPPL 1): 146, 1989

Studying mechanisms of eryptosis. Cytotechnology 49(2-3): 117-132, 2005

The impact of erythrocyte age on eryptosis. British Journal of Haematology 157(5): 606-614, 2012

Mechanisms and significance of eryptosis. Antioxidants & Redox Signaling 8(7-8): 1183-1192, 2006

Eryptosis: Ally or Enemy. Current Medicinal Chemistry: -, 2016